{"podcast":{"title":"Frankly Speaking About Family Medicine","slug":"frankly-speaking-about-family-medicine-434006","podcast_index_feed_id":434006,"rss_url":"https://feed.podbean.com/primedfranklyspeaking/feed.xml","website_url":"https://primedfranklyspeaking.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/13721080/PRM-123_DPL_mediaplayer_frankly-speaking_x7npub.jpg","author":"Pri-Med","episode_count":503,"summary":"A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com","last_synced_at":"2026-07-20T12:18:28.603391+00:00","page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006"},"episode":{"title":"Are You Still Recommending Aspirin for Primary Prevention? - Frankly Speaking Ep 468","slug":"are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468","published_at":"2026-01-19T05:30:00+00:00","page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468","show_page_url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006","url":"https://primedfranklyspeaking.podbean.com/e/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-467/","audio_url":"https://mcdn.podbean.com/mf/web/debmji7n42merkxu/episode-467-aspirin-CV-events.mp3","summary":"Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468 Overview: We first discussed aspirin use for primary prevention of cardiovascular disease in 2022 when the USPSTF recommended against it. In this follow-up episode, we review new trial data reinforcing that guidance and help you translate the evidence into safer prevention strategies. Build confidence in supporting patients with evidence-based approaches to reduce cardiovascular risk. Episode resource links: Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial. Eur Heart J. 2025 Aug 12:ehaf514. doi: 10.1093/eurheartj/ehaf514. Epub ahead of print. PMID: 40796244. Guest: Robert A. Baldor MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.","meta_description":"Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-468 Ov…","key_points":[],"chapters":[],"topics":[],"duration_seconds":583,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/are-you-still-recommending-aspirin-for-primary-prevention-frankly-speaking-ep-468.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}